H.R. 4369 · 117th Congress

National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021

Stage
Passed a chamber
Sponsor
Frank Pallone
Introduced
2021-07-06
Latest action
2021-10-20 · Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Action history

  1. 2021-10-20Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. 2021-10-19The title of the measure was amended. Agreed to without objection.
  3. 2021-10-19Motion to reconsider laid on the table Agreed to without objection.
  4. 2021-10-19On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 368 - 56 (Roll no. 318).
  5. 2021-10-19Considered as unfinished business.
  6. 2021-10-19At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  7. 2021-10-19DEBATE - The House proceeded with forty minutes of debate on H.R. 4369.
  8. 2021-10-19Considered under suspension of the rules.
  9. 2021-10-19Mr. Pallone moved to suspend the rules and pass the bill, as amended.
  10. 2021-10-19Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-151.
  11. 2021-10-19Placed on the Union Calendar, Calendar No. 111.
  12. 2021-07-21Committee Consideration and Mark-up Session Held.
  13. 2021-07-21Ordered to be Reported (Amended) by Voice Vote.
  14. 2021-07-15Subcommittee Consideration and Mark-up Session Held.
  15. 2021-07-15Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
  16. 2021-07-07Referred to the Subcommittee on Health.
  17. 2021-07-06Introduced in House
  18. 2021-07-06Referred to the House Committee on Energy and Commerce.